ClinicalTrials.gg
CompletedNCT05782088Updated Mar 26, 2024

Single Versus Repeated Piezocision-assisted Orthodontic Tooth Movement

An interventional study of Single Piezocision and Repeated Piezocision in Orthodontic Tooth Movement and Canine Retraction, sponsored by Nourhan M.Aly. Completed at 1 site in Egypt. Open to participants aged 15 Years to 25 Years. Per ClinicalTrials.gov, last updated 2024-03-26.

Sponsored by Nourhan M.Aly · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
15 Years to 25 Years
Sex
All
01

Study summary

The primary aim of the study is to evaluate the effect of single and repeated piezocisions on the rate of orthodontic tooth movement. Secondary aims are to evaluate the effect of both protocols on molar anchorage loss, as well as on canine root resorption.

02

Conditions studied

  • Orthodontic Tooth Movement
  • Canine Retraction
03

In context

Lead sponsor

Nourhan M.Aly is the lead sponsor of 49 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Malocclusion that requires at least the extraction of maxillary first premolars, such as Class I bimaxillary protrusion, and Class II division 1 cases.
  • Normal shape and structure of the maxillary canines, with no history of root canal treatment

Exclusion criteria

Exclusion Criteria:

  • Patients who underwent previous orthodontic treatment.
  • Patients currently receiving drug therapy that may affect orthodontic tooth movement, e.g. hormonal therapy and .
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Single Piezocision

    Procedure: Single Piezocision

  • Experimental
    Repeated Piezocision

    Procedure: Repeated Piezocision

Interventions

  • ProcedureSingle Piezocision

    Piezocision will be performed only once before the onset of canine retraction (T0) on one side of the maxillary arch that will be randomly chosen.

  • ProcedureRepeated Piezocision

    Piezocision will be repeated three times, on a monthly basis (T0, T1, and T2), over the 12-week study period.

06

What researchers measure

Primary outcomes

  1. Measurement of canine retraction

    Several landmarks will be identified on the dental arch, including the mid-palatal raphe, the most medial points on the third right and left rugae, and the cusp tips of the right and left maxillary canines. Perpendicular lines will be drawn from the medial points of the right and left third rugae, and the cusp tips of the right and left maxillary canines to the mid-palatal raphe. The antero-posterior measurements will be carried out between the canine lines and the third rugae lines bilaterally, to assess the rate of canine retraction.

    Time frame: 12 weeks

  2. Measurement of molar anchorage loss

    Perpendicular lines will be drawn from the central fossae of both maxillary right and left first molars to the mid-palatal raphe. Consequently, molar anchorage loss will be calculated by measuring the distance between those lines, and the lines representing the third rugae as previously mentioned.

    Time frame: 12 weeks

  3. Measurement of canine root resorption

    Root resorption of the maxillary canines will be evaluated and measured by comparing pre-retraction and post-retraction CBCT scans.

    Time frame: 12 weeks

  4. Bone Microstructure (Fractal Dimension)

    Using the collected CBCT scans, the region of interest will be selected within the maxillary alveolar process, and the fractal dimension analysis will be performed using a special software for the maxillary canines in the experimental and control groups.

    Time frame: 12 weeks

  5. Alveolar bone density

    From the acquired pre- and post-retraction CBCTs, bone density will be measured form a coronal cross-section of the maxillary arch around each canine in the experimental and control groups.

    Time frame: 12 weeks

  6. Alveolar bone thickness

    The buccal bone thickness will also be measured at three points from the buccal bone to the root, at the coronal, mid-root, and apical level for each maxillary canine

    Time frame: 12 weeks

  7. Alveolar bone volume

    From the pre- and post-retraction CBCTs (at T0 and T1), bone volume in areas of the maxillary alveolar process surrounding the canines will be measured using a special software.

    Time frame: 12 weeks

  8. Maxillary canine tipping

    Tipping of the maxillary canine during retraction was evaluated by drawing vertical lines on the palatal surfaces of the lateral incisor and the canine that extend from the middle of the incisal edge of the lateral incisor and the cusp tip of the maxillary canine to the middle of the cervical line of each, thereby dividing each of them into equal halves. The distance between the lateral incisor and the canine was assessed at two points on their clinical crowns: incisal, and cervical, enabling the detection of crown tipping of the canine during retraction if there was a difference in the measurements between the both the assessed levels.

    Time frame: 12 weeks

07

Study locations

1 site
  • Faculty of Dentistry, Alexandria University
    Alexandria, 21512, Egypt
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2023 to primary completion in Jan 2024, 12 months.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 12, 2023
First posted
Mar 23, 2023
StartActual
Jan 1, 2023
Primary completionActual
Jan 1, 2024
CompletionActual
Jan 15, 2024
Last update
Mar 26, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 26, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05782088
Lead sponsor
Nourhan M.Aly
Responsible party
Nourhan M.Aly (Assistant Lecturer of Dental Public Health, University of Alexandria) — Sponsor-investigator
First posted
Mar 23, 2023
Start date
Jan 1, 2023
Primary completion
Jan 1, 2024
Completion
Jan 15, 2024
Last update
Mar 26, 2024

Study contacts

Farah Y Eid, PhD
principal investigator · Alexandria University
Ahmed R El-Kalza, PhD
study director · Alexandria University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion